ICRA upgrades Indoco Remedies’ long term rating to ‘AA-’

23 Jul 2021 Evaluate

Credit rating agency -- ICRA has upgraded Indoco Remedies’ long term rating to ‘AA-’ from ‘A+’. The outlook on the long-term rating is stable. The short term rating of company has been revised to ‘A1+’ from ‘A1’.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

234.80 4.15 (1.80%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×